Skip to main content
FARON PHARMACEUTICALS OY logo

FARON PHARMACEUTICALS OY — Investor Relations & Filings

Ticker · FARN ISIN · FI4000153309 LEI · 7437009H31TO1DC0EB42 IL Manufacturing
Filings indexed 625 across all filing types
Latest filing 2026-05-13 Regulatory Filings
Country FI Finland
Listing IL FARN

About FARON PHARMACEUTICALS OY

https://faron.com/

Faron Pharmaceuticals is a clinical-stage biopharmaceutical company focused on developing innovative immunotherapies for cancer. The company pioneers macrophage-targeting therapies to leverage the patient's immune system, aiming to address unmet medical needs and improve outcomes. Its lead asset, bexmarilimab, is a first-in-class anti-Clever-1 antibody and a myeloid cell-targeting immunotherapy candidate. Bexmarilimab is being investigated in clinical trials as a potential therapy for hematological malignancies and solid tumors, often in combination with standard-of-care treatments.

Recent filings

Filing Released Lang Actions
Faron to present new BEXMAB translational and clinical data in HR-MDS at EHA 2026
Regulatory Filings Classification · 85% confidence The document is a corporate press release announcing the acceptance of a scientific abstract for presentation at a conference and details of an upcoming webcast. It does not contain financial results, board changes, voting matters, legal proceedings, or any formal report or filing. It is a general company announcement distributed via a regulatory news service, fitting the fallback category for miscellaneous regulatory news. Therefore, it should be classified as a Regulatory Filing (RNS).
2026-05-13 English
Faron Pharmaceuticals Ltd: Termination of Liquidity Provision Service
Regulatory Filings
2026-05-06 English
FARON PHARMACEUTICALS LTD: HOLDING(S) IN COMPANY
Regulatory Filings
2026-05-05 English
Faron Pharmaceuticals Ltd: Directorate Appointment
Regulatory Filings
2026-05-05 English
Faron Pharmaceuticals Ltd: Results of the Annual General Meeting
AGM Information
2026-05-04 English
Faron Pharmaceuticals Ltd: Issuance of warrants
Share Issue/Capital Change
2026-04-30 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.